 Codexis Inc. CDXS shares fell in the extended session Thursday after the biotech company lowered its revenue forecast for the year and said that sales from Pfizer Inc. PFE would come in at the low end of an expected range. Codexis shares dropped more than 20 after hours, following a 4.7 decline in the regular session to close at 12.07. 